SEC Filing Update: #AVTX Avalo Therapeutics, Inc. : $19.75

Sector: Healthcare | YTD: 🔼+ 16.31% The SEC disclosed Today (14-AUG-2026) that RA CAPITAL MANAGEMENT has INCREASED #AVTX Shares by 248.31% 🟢 Deep Track Capital, LP also reported an increase in its holdings on the same day. BIOTECHNOLOGY VALUE FUND L P also reported an increase in its holdings on the same day. * Previous Holdings: 1.00M Shares * Current Holdings: 3.48M Shares * Increase+2.48M * Increased(%)+248.31% * Ownership: 6.3% * Estimated Investment Value: $47.23M https://www.thinksabio.com/reports/isr/AVTX Institutional ownership in #AVTX has been steadily rising over the past 4 quarters in Shares: Q2 2025: 7.84M Q3 2025: 15.32M Q4 2025: 19.89M Q1 2026: 31.10M 📌 Institutional activity in the last 30 days for #AVTX: • FMR LLC – Increased holdings by 637,750 shares (07-AUG-2026) • Deep Track Capital, LP – Increased holdings by 554,973 shares (14-AUG-2026) • BIOTECHNOLOGY VALUE FUND L P – Increased holdings by 207,782 shares (14-AUG-2026) • BLACKROCK INC – Increased holdings by 3,088,649 shares (27-JUL-2026)